Breast Cancer
Women treated with trastuzumab have increased risk of metastases to the brain
Published in Women's Health Weekly, June 26th, 2003
Findings reported in the June 15, 2003 issue of Cancer indicate that more than 33% of women with metastatic breast cancer who overexpress the HER2 receptor and are treated with trastuzumab, develop symptomatic CNS metastases, often times in spite of decreased or stable metastatic disease elsewhere in the body.
The authors suggested that because of the devastating impact of neurological impairment and the high incidence of brain metastases while on trastuzumab, "it may be worthwhile to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Polycystic Ovary Syndrome
PCOS increases risk of heart disease in women - Endocrinology
Estrogen coordinately upregulates RA production, signaling in human endometrium - Miscarriage
Spontaneous abortion is more likely in young women with older male partners - Osteoporosis
Hard palate protrusions correlate with bone density in postmenopausal women - Polycystic Ovarian Syndrome
Mechanism of catecholamine resistance in polycystic ovarian syndrome reviewed - Anti-Candida Antibodies
Highly specific antibodies to cell wall beta-glucans are in normal human sera - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
